Preparation of in situ-forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: In vitro and in vivo studies

Journal of Pharmaceutical Sciences

Volumn 92, Issue 2, 2003, Pages 407-413

  Charoo, Naseem A ^a   Kohli, Kanchan ^a   Ali, Asgar ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Bacterial conjunctivitis; Ciprofloxacin hydrochloride; Sol to gel system

Indexed keywords

ACETIC ACID; AGENTS ACTING ON THE EYE; BENZALKONIUM CHLORIDE; CARBOMER; CIPROFLOXACIN; EYE DROPS; HYDROXYPROPYLMETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE K15M; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CONJUNCTIVITIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG STERILITY; DRUG SYNTHESIS; FEMALE; FILTRATION; FLOW KINETICS; GAMMA RADIATION; GEL; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHASE TRANSITION; RABBIT; SHELF LIFE;

EID: 0037308399     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10290     Document Type: Article

References (10)

1. Kramer SG. 1984. Survey Ophthalmol 29(2):117-128.
2. Kamath R, Singh UV, Udupa N. 1993. Evaluation of ciprofloxacin hydrochloride ocular preparations. Ind J Pharm Sci 55:148-150.
3. Tsai AC, Tseng MC, Chang SW, Hu FR. 1995. Clinical evaluation of ciprofloxacin ophthalmic solution in the treatment of refractory bacterial keratitis. J Formos Med Assoc 94(12):760-764.
4. Ciprofloxacin hydrochloride, analytical report, control no. 197210, WHO Guidelines. 1997. WHO/Pharm 595:57-65.
5. Edsman K, Carlfors J, Harju K. 1996. Rheological evaluation and ocular contact time of some carbomer gels for ophthalmic use. Int J Pharm 137:233-241.
6. Sarkar N. 1979. Thermal gelation properties of methyl and HPMC. J Appl Polym Sci 24:1073-1087.
7. Kumar S, Haglund BO, Himmelstein KJ. 1994. In situ forming gels for ophthalmic drug delivery. J Ocular Pharmacol 1:10.
8. Lindell K, Engstrom S. 1993. In vitro release of timolol maleate from an in situ gelling polymer system. Int J Pharm 95:219-228.
9. Cekic O, Batman C, Yasar U, Atilla F. 1998. Comparison of aqueous humor and vitreous humor levels of two 0.3% ciprofloxacin eye drops. Can J Ophthalmol 33:373-376.
10. Isavadharm PT, Keeratithakul D, Watt G, Webster HK, Edstein MD. 1991. Measurement of ciprofloxacin in human plasma, whole blood and erythrocytes by high performance liquid chromatography. Ther Drug Monit 13(3):263-267.